Two quite different types of research have been invaluable in elucidating principles in the field of molecular biology: biochemistry and genetics. When those two approaches intersect, as they have in recent work on eukaryotic transcription control, the resulting reverberation has the ring of truth. In a recent issue of these Proceedings, Li et al. (1) 
Two quite different types of research have been invaluable in elucidating principles in the field of molecular biology: biochemistry and genetics. When those two approaches intersect, as they have in recent work on eukaryotic transcription control, the resulting reverberation has the ring of truth. In a recent issue of these Proceedings, Li et (6) . Activators stimulate transcription in cell-free in vitro reactions using complex extracts prepared from isolated cell nuclei. However, they fail to stimulate transcription in reactions with the purified general transcription factors. Working in the budding yeast system, Roger Kornberg and co-workers went back to the complex nuclear extract to search for an activity that would allow activators to stimulate transcription in the in vitro reaction with purified general transcription factors. They succeeded in identifying such an activity, calling it mediator (7). As they purified and analyzed mediator (8) , it became apparent that they were characterizing the same multiprotein complex that was concurrently discovered by Richard Young and colleagues (24) through what was initially a genetic strategy for the analysis of transcription control. This was the initial intersection of the biochemical and genetic studies that led to the discovery of the holoenzyme.
Young and colleague's genetic strategy began with an analysis of a unique structural aspect of RNA polymerase II, a specific C-terminal domain (CTD) associated with its largest subunit (9, 10) . The CTD is composed of 26-52 tandem copies (depending on the organism) of nearly perfect repeats of a seven amino acid residue sequence, Tyr-Ser-Pro-Thr-SerPro-Ser. When RNA polymerase II is assembled into the massive preinitiation complex at eukaryotic promoters, its CTD is unmodified. As the polymerase initiates transcription and then transcribes away from the initiation site on the template, the CTD is phosphorylated at multiple sites (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . A number of protein kinases have been identified that can phosphorylate the CTD, but the Cdk7 subunit of TFIIH appears to be responsible for most CTD phosphorylations in in vitro transcription reactions (15) . In these in vitro reactions, Cdk7 phosphorylation of the CTD is required for transcription from some promoters (16) but not others (15) .
Genetic experiments using the methods of site-directed mutagenesis revealed that the CTD is essential for the viability of budding yeast, Drosophila, and mammalian cells (17) (18) (19) (20) . To (22, 24) . [However, the critical TFIID factor that binds to the TATA-box sequence of eukaryotic promoters was not present in the complex (24) ]. The multiprotein complex they purified from yeast nuclear extracts was very similar to the complex identified by Kornberg and co-workers during their purification of mediator activity (8) . Both groups agreed to call the complex the holoenzyme. While there are potentially important differences between the composition of the holoenzymes described by the two groups, the many similarities seem more significant than the differences. In experiments with cells having temperature-sensitive srb4 or srb6 mutations, the transcription of multiple genes shut down rapidly when the cells were shifted to the nonpermissive temperature (25 mutants, Gal4 activation is impaired (29) . Additional studies revealed that galll mutations have a general defect that reduces the ability of multiple activators to stimulate transcription (30, 31) . With this precedent in mind, Li et al. (1) tested whether any of the unidentified mediator/Srb complex polypeptides might be encoded by other genes which have generalized effects on transcription.
Li et al. (1) focused on the genes SIN4 and RGRI because they realized that the published characteristics of cells with mutations in these genes were similar to those of gall] mutants (32) (33) (34) . Indeed, specific antibody to Sin4 protein revealed that it purifies with the holoenzyme, and peptide microsequencing revealed that another previously unidentified polypeptide in the complex is encoded by the RGRI gene (1) . Thus, earlier studies indicating that the Galll, Sin4, and Rgrl proteins are required for maximal transcriptional activation by a number of different enhancers can now be explained by the association of these proteins with the holoenzyme, which is required for the transcription of many, if not all, genes (25) . Sugl, another polypeptide first identified through genetic studies (35) , is also a component of the holoenzyme (1) . Moreover 
